ANI Pharmaceuticals reports positive phase 4 uveitis trial data

October 12, 2026 6:55 AM

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) announced results from its SYNCHRONICITY Phase 4 clinical trial evaluating a fluocinolone acetonide intravitreal ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found